167 related articles for article (PubMed ID: 34287678)
61. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature.
Blake EA; Carter CM; Kashani BN; Kodama M; Mabuchi S; Yoshino K; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():1-7. PubMed ID: 24439718
[TBL] [Abstract][Full Text] [Related]
62. Use of staging for sex cord stromal tumours.
Negri S; Grassi T; Fruscio R
Curr Opin Oncol; 2022 Sep; 34(5):504-510. PubMed ID: 35849655
[TBL] [Abstract][Full Text] [Related]
63. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.
Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynaecol Obstet; 2016 Jul; 134(1):49-52. PubMed ID: 27039052
[TBL] [Abstract][Full Text] [Related]
64. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
65. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
66. A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women.
Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
BMC Cancer; 2020 Oct; 20(1):1009. PubMed ID: 33076846
[TBL] [Abstract][Full Text] [Related]
67. Sexuality and quality of life after nerve-sparing radical hysterectomy for cervical cancer: A prospective study.
Novackova M; Pastor Z; Chmel R; Mala I; Chmel R
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):641-645. PubMed ID: 35779914
[TBL] [Abstract][Full Text] [Related]
68. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
[TBL] [Abstract][Full Text] [Related]
69. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary.
Talukdar S; Kumar S; Bhatla N; Mathur S; Thulkar S; Kumar L
Gynecol Oncol; 2014 Jan; 132(1):28-32. PubMed ID: 24145115
[TBL] [Abstract][Full Text] [Related]
70. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
Huang Y; Zhang W; Wang Y
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
[TBL] [Abstract][Full Text] [Related]
71. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
[TBL] [Abstract][Full Text] [Related]
72. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
Jiang X; Yang J; Yu M; Xie W; Cao D; Wu M; Pan L; Huang H; You Y; Shen K
World J Surg Oncol; 2017 Aug; 15(1):154. PubMed ID: 28806962
[TBL] [Abstract][Full Text] [Related]
73. Expression of Transcription Factors and Nuclear Receptors in Mixed Germ Cell-Sex Cord Stromal Tumor and Related Tumors of the Gonads.
Roth LM; Cheng L
Int J Gynecol Pathol; 2015 Nov; 34(6):528-34. PubMed ID: 26107563
[TBL] [Abstract][Full Text] [Related]
74. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
[TBL] [Abstract][Full Text] [Related]
75. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
76. Reproductive outcomes following fertility-sparing surgery for malignant ovarian germ cell tumors: A systematic review of the literature.
Morrison A; Nasioudis D
Gynecol Oncol; 2020 Aug; 158(2):476-483. PubMed ID: 32513565
[TBL] [Abstract][Full Text] [Related]
77. Age-dependent difference in impact of fertility preserving surgery on disease-specific survival in women with stage I borderline ovarian tumors.
Sun H; Chen X; Zhu T; Liu N; Yu A; Wang S
J Ovarian Res; 2018 Jun; 11(1):54. PubMed ID: 29958541
[TBL] [Abstract][Full Text] [Related]
78. Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.
Kim SI; Lee Y; Lim MC; Joo J; Park K; Lee DO; Park SY
J Gynecol Oncol; 2015 Apr; 26(2):148-54. PubMed ID: 25686396
[TBL] [Abstract][Full Text] [Related]
79. The significance of comprehensive staging surgery in malignant ovarian germ cell tumors.
Liu Q; Ding X; Yang J; Cao D; Shen K; Lang J; Zhang G; Xin X; Xie X; Wu Y
Gynecol Oncol; 2013 Dec; 131(3):551-4. PubMed ID: 24007946
[TBL] [Abstract][Full Text] [Related]
80. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors.
Plett H; Harter P; Ataseven B; Heitz F; Prader S; Schneider S; Heikaus S; Fisseler-Eckhoff A; Kommoss F; Lax SF; Staebler A; Traut A; du Bois A
Gynecol Oncol; 2020 May; 157(2):411-417. PubMed ID: 32115229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]